Pharmacotherapy for Cardiovascular Disorders
Cardiovascular diseases (CVDs) are disorders that affect the heart and blood vessels. They include Hypertension, cerebrovascular disease, coronary heart disorders, hyperlipidemia, among others. CVDs rank among the leading causes of deaths in the United States. In 2015 alone, 17 million deaths from CVDs were recorded, making it the leading cause of deaths worldwide. CVDs were also linked to high levels of obesity and type 2 diabetes.
Cardiovascular Pharmacotherapy is a new, very complex discipline in cardiology that plays a significant role in the treatment and management of cardiovascular disorders. It is a form of drug therapy that has shown a great deal of help in controlling, improving, and managing cardiovascular diseases. The mechanism of cardiovascular pharmacology is to debilitate symptoms, thereby prolonging and enhancing the quality of life.
In the past couple of years, physicians have continually tested and benefited from the discovery of a diverse range of pharmacological agents that are critical in managing cardiovascular disorders. Few notable areas that have significantly benefited from the arrival of these pharmacological agents are diabetes, dyslipidemia, heart failure coronary artery diseases, stroke prevention and management, thrombosis, a couple of coagulation disorders, and cardiac arrhythmias such as atrial fibrillation.
However, people react differently to different medications. The reaction may be influenced by various factors such as age, gender, race, background, metabolic phenotype, fat content, and distribution in the body. Interaction of a drug with another drug, with the disease and how it relates to sex and hormonal changes, should be considered as it determines the effects, especially on female patients.
The arrival of these pharmacological agents has also stirred up challenges for the Physicians. Medical professionals need to learn and understand the mechanisms of treatment and possible side effects of these drugs. Physicians are also required to have a clear understanding of the pharmacological characteristics of the drug to ensure that they only make informed prescription decisions.
As such, frequent and random trials should be conducted to study and address such issues. The effectiveness of a given combination of drugs in treating cardiovascular disorders must be tested, demonstrated, and proven to be effective before being practiced on the general population. Even minority groups with low social, economic status in the United States are at risk of getting cardiovascular diseases. Therefore, research should be conducted to ensure that the pharmacotherapy availed is helpful to this part of the population. Pharmacotherapy has great potential in the treatment and management of CVDs. However, additional studies, research, and evaluation are crucial in ensuring success.
EHR Implementation Training Plan
EHR Implementation Training Plan Having budgeted and selected the appropriate HER system for your facility, the next crucial step is the implementation process. Effective training remains central in the implementation process. The value of EHR to healthcare solely depends on the user’s ability to utilize new technology in daily operations. For a successful EHR implementation, […]
